Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20140818018842N39Phase 2Completed
Phase 2, single-arm trial of thiotepa in acute lymphoblastic leukemia (ALL), sponsored by Tehran University of Medical Sciences. Started Apr 2024; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20140818018842N39.